首页> 外国专利> MALEIC ACID 3-METHYL-2-PYRIDYLAMIDE ELICITING DIRECT ANTICOAGULANT EFFECT

MALEIC ACID 3-METHYL-2-PYRIDYLAMIDE ELICITING DIRECT ANTICOAGULANT EFFECT

机译:马来酸3-甲基-2-吡啶酰胺直接起抗凝作用

摘要

FIELD: organic chemistry, chemical technology, medicine, hematology.;SUBSTANCE: invention relates to using maleic acid 3-methyl-2-pyridylamide of the formula: in medicine as an anticoagulant agent. Compound is synthesized by interaction of 2-amino-3-methylpyridine with maleic anhydride. Synthesized compound is a white crystalline substance with value Tm = 136-137°C and soluble in water, ethanol, dimethylformamide (DMFA) and dimethylsulfoxide (DMSO). Synthesized substance provides increasing coagulating time of citrate blood and percent for coagulating capacity change in the concentration of this substance 1 mg/ml and 0.5 mg/ml by 502.4% and 92.2%, respectively. Value LD50 for this substance is 20.5 (12.2-31.3) mg/kg after its intravenous injection in white mice.;EFFECT: valuable medicinal property of compound.;1 tbl
机译:技术领域:本发明涉及使用下式的马来酸3-甲基-2-吡啶酰胺:<图像文件=“ 00000002.GIF” he =“ 26” id =“ imag00000002医学上用作抗凝剂的“ imgContent =“ undefined” imgFormat =“ GIF” wi =“ 55” />。通过2-氨基-3-甲基吡啶与马来酸酐的相互作用合成化合物。合成的化合物是白色结晶物质,其值T m = 136-137℃,可溶于水,乙醇,二甲基甲酰胺(DMFA)和二甲基亚砜(DMSO)。合成的物质增加了柠檬酸盐血液的凝固时间,并使该物质浓度为1 mg / ml和0.5 mg / ml的凝固能力变化的百分比分别增加了502.4%和92.2%。该物质经静脉注射后在白色小鼠中的LD 50 值为20.5(12.2-31.3)mg / kg。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号